Biggest News Aggregation in the World
๐Ÿ“ฐ Beigene News

Page 20 - Beigene News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.

BeiGene (NASDAQ:BGNE) Shares Gap Down to $184.00

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) gapped down before the market opened on Friday . The stock had previously closed at $184.00, but opened at $177.01. BeiGene shares last traded at $177.20, with a volume of 1,257 shares. BGNE has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft initiated coverage […]
United States Jane Huang Xiao Dong Wang Morgan Stanley Zacks Investment Research Amundi Pioneer Asset Management Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Fierce Pharma Asia—Takeda, Denali's Alzheimer's hiccup; Daiichi Sankyo's R&D reorg; J&J, Legend's CAR-T supply prep

The FDA has slapped a clinical hold on Takeda and Denali Therapeutics' phase 1-ready Alzheimer's candidate. Daiichi Sankyo is shutting down its Plexxikon R&D facility. Legend Biotech talks manufacturing learnings from Bristol Myers Squibb's CAR-T rival.
South Korea South Korean Innovent Biologics Richard Pazdur Daiichi Sankyo Susanne Schaffert

Novartis, BeiGene ink another deal; plan for tests of checkpoint cancer drug combos

Novartis is partnering with BeiGene on the development of a drug that addresses TIGIT, a hot cancer immunotherapy target. The Swiss pharma giant is committing $300 million up front, and up to $700 million more upon exercising its option on BeiGene's antibody drug.
United States Merck Keytruda Susanne Schaffert Gilead Sciences European Union Bristol Myers Squibb

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science